Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells — Javier A. Menéndez (2007) | RDL Network
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
Article 2007 en
Authors
JM
Javier A. Menéndez
AV
Alejandro Vázquez‐Martín
RC
Rámón Colomer
Abstract
1 min read
Olive oil's bitter principle (i.e., oleuropein aglycone) is among the first examples of how selected nutrients from an EVOO-rich "Mediterranean diet" directly regulate HER2-driven breast cancer disease.
Niki Kontou, Demosthenes B. Panagiotakos, Θεοδώρα Ψαλτοπούλου, Nick Soupos, Evangelos Polychronopoulos, Dimitris Xynopoulos, Dimitrios Dimitroulopoulos, A. González de Aledo Linos, E. Paraskevas, Meletios A Dimopoulos
Marta Rossi, Greta Carioli, Martina Bonifazi, Alberto Zambelli, Matteo Franchi, Lorenzo Moja, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri
Discussion(0)
No comments yet. Be the first to comment.